Connecting you to content on EBSCOhost

Works by D'Amelio, Anthony M.

Results: 4

1

Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors.

Published in:

2020

By:

Tolcher, Anthony W.;
Kurzrock, Razelle;
Valero, Vincente;
Gonzalez, Rene;
Heist, Rebecca S.;
Tan, Antoinette R.;
Means-Powell, Julie;
Werner, Theresa L.;
Becerra, Carlos;
Wang, Chenxi;
Leonowens, Cathrine;
Kalyana-Sundaram, Shanker;
Kleha, Joseph F.;
Gauvin, Jennifer;
D'Amelio, Anthony M.;
Ellis, Catherine;
Ibrahim, Nageatte;
Yan, Li;
D'Amelio, Anthony M Jr

Publication type:

journal article

2

Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma.

Published in:

Radiation Oncology, 2012, v. 7, n. 1, p. 116, doi. 10.1186/1748-717X-7-116

By:

Howell, Rebecca M.;
Giebeler, Annelise;
Koontz-Raisig, Wendi;
Mahajan, Anita;
Etzel, Carol J.;
D'Amelio Jr., Anthony M.;
Homann, Kenneth L.;
Newhauser, Wayne D.

Publication type:

Article

3

Hodgkin disease risk: Role of genetic polymorphisms and gene-gene interactions in inflammation pathway genes.

Published in:

Molecular Carcinogenesis, 2011, v. 50, n. 1, p. 36, doi. 10.1002/mc.20688

By:

Monroy, Claudia M.;
Cortes, Andrea C.;
Lopez, Mirtha S.;
D'Amelio, Anthony M.;
Etzel, Carol J.;
Younes, Anas;
Strom, Sara S.;
El-Zein, Randa A.

Publication type:

Article

4

Bioequivalence study with lapatinib powder for oral suspension and the original tablet formulation in cancer patients.

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 3, p. 203, doi. 10.1002/cpdd.139

By:

Koch, Kevin M.;
Ferron-Brady, Geraldine;
Lemmon, Colleen;
Cartee, Leanne;
Hollyfield, Hedy;
D'Amelio, Anthony M.;
Piepszak, Alexandra;
Swaby, Ramona F.;
Curran, David;
Arya, Niki

Publication type:

Article